Home » Newsletters » BioWorld

BioWorld

Sep. 7, 2004

View Archived Issues

World's Largest Nation Drawing Attention From Biotech, Pharma

States Angling To Control Reimportation, Stem Cells

Holiday Notice

BioWorld Today's offices are closed Monday, Sept. 6, in observance of Labor Day. No issue will be published. Read More

Other News To Note

MediciNova $44M Financing To Advance Products To Phase II

As it prepares to move three products into Phase II studies, MediciNova Inc. raised $44 million in a Series C round. (BioWorld Today) Read More

NeoPharm's Kapoor Makes Bid To Change Board, Reduce Costs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...